Skip to Content

UK Edition. Click here for US version.

MEMANTINE HYDROCHLORIDE 5 MG / 10 MG / 15 MG / 20 MG FILM-COATED TABLETS INITIATION PACK

Active substance(s): MEMANTINE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
MEMANTINE HYDROCHLORIDE INITIATION PACK
PACKAGE�LEAFLET:�INFORMATION�FOR�THE�USER
Memantine�hydrochloride�5�mg�/�10�mg�/�15�mg�/�20�mg�film-coated�tablets�initiation�pack
7�tablets�of�Memantine�hydrochloride�5�mg�film-coated�tablets
7�tablets�of�Memantine�hydrochloride�10�mg�film-coated�tablets
7�tablets�of�Memantine�hydrochloride�15�mg�film-coated�tablets
7�tablets�of�Memantine�hydrochloride�20�mg�film-coated�tablets
Memantine�hydrochloride
Read�all�of�this�leaflet�carefully�before�you�start�taking�this�medicine�because�it�contains�important�
information�for�you
-�Keep�this�leaflet.�You�may�need�to�read�it�again.
-�If�you�have�any�further�questions,�ask�your�doctor�or�pharmacist.
-�This�medicine�has�been�prescribed�only�for�you.�Do�not�pass�it�on�to�others.�It�may�harm�them,�even�if�their�signs�of�
illness�are�the�same�as�yours.
-�If�any�of�the�side�effects�gets�serious,�or�if�you�notice�any�side�effects�not�listed�in�this�leaflet,�please�tell�your�doctor�
or�pharmacist.
In�this�leaflet
1.�What�Memantine�hydrochloride�is�and�what�it�is�used�for
2.�What�you�need�to�know�before�you�take�Memantine�hydrochloride
3.�How�to�take�Memantine�hydrochloride
4.�Possible�side�effects
5.�How�to�store�Memantine�hydrochloride
6.�Content�of�the�pack�and�other�information
1.�WHAT�MEMANTINE�HYDROCHLORIDE�IS�AND�WHAT�IT�IS�USED�FOR
How�does�Memantine�hydrochloride�work
Memantine�hydrochloride�belongs�to�a�group�of�medicines�known�as�anti-dementia�medicines.
Memory� loss� in� Alzheimer’s� disease� is� due� to� a� disturbance� of� message� signals� in� the� brain.� The� brain� contains�
so-called� N-methyl-D-aspartate� (NMDA)-receptors� that� are� involved� in� transmitting� nerve� signals� important� in�
learning�and�memory.�Memantine�hydrochloride�belongs�to�a�group�of�medicines�called�NMDA-receptor�antagonists.�
Memantine� hydrochloride� acts� on� these� NMDA-receptors� improving� the� transmission� of� nerve� signals� and� the�
memory.
What�is�Memantine�hydrochloride�used�for
Memantine�hydrochloride�is�used�for�the�treatment�of�patients�with�moderate�to�severe�Alzheimer’s�disease.
2.�WHAT�YOU�NEED�TO�KNOW�BEFORE�YOU�TAKE�MEMANTINE�HYDROCHLORIDE
Do�not�take�Memantine�hydrochloride
-� if� you� are� allergic� to� memantine� hydrochloride� or� any� of� the� other� ingredients� of� Memantine� hydrochloride�
film-coated�tablets�(see�section�6).
Warnings�and�precautions
-�if�you�have�a�history�of�epileptic�seizures
-�if�you�have�recently�experienced�a�myocardial�infarction�(heart�attack),�or�if�you�are�suffering�from�congestive�heart�
failure�or�from�an�uncontrolled�hypertension�(high�blood�pressure).
In�these�situations�the�treatment�should�be�carefully�supervised,�and�the�clinical�benefit�of�Memantine�hydrochloride�
reassessed�by�your�doctor�on�a�regular�basis.
If�you�suffer�from�renal�impairment�(kidney�problems),�your�doctor�should�closely�monitor�your�kidney�function�and�
if�necessary�adapt�the�memantine�doses�accordingly.
The�use�of�medicinal�products�called�amantadine�(for�the�treatment�of�Parkinson’s�disease),�ketamine�(a�substance�
generally�used�as�an�anaesthetic),�dextromethorphan�(generally�used�to�treat�cough)�and�other�NMDA-antagonists�at�
the�same�time�should�be�avoided.
Children�and�adolescents
Memantine�hydrochloride�is�not�recommended�for�children�and�adolescents�under�the�age�of�18�years.
Other�medicines�and�Memantine�hydrochloride
Please�tell�your�doctor�or�pharmacist�if�you�are�taking�or�have�recently�taken�any�other�medicines,�including�medicines�
obtained�without�a�prescription.
In�particular,�Memantine�hydrochloride�may�change�the�effects�of�the�following�medicines�and�their�dose�may�need�to�
be�adjusted�by�your�doctor:
amantadine,�ketamine,�dextromethorphan
dantrolene,�baclofen
cimetidine,�ranitidine,�procainamide,�quinidine,�quinine,�nicotine
hydrochlorothiazide�(or�any�combination�with�hydrochlorothiazide)
anticholinergics�(substances�generally�used�to�treat�movement�disorders�or�intestinal�cramps)
anticonvulsants�(substances�used�to�prevent�and�relieve�seizures)
barbiturates�(substances�generally�used�to�induce�sleep)
dopaminergic�agonists�(substances�such�as�L-dopa,�bromocriptine)
neuroleptics�(substances�used�in�the�treatment�of�mental�disorders)
oral�anticoagulants
If�you�go�into�hospital,�let�your�doctor�know�that�you�are�taking�Memantine�hydrochloride.
Memantine�hydrochloride�with�food�and�drink
You�should�inform�your�doctor�if�you�have�recently�changed�or�intend�to�change�your�diet�substantially�(e.g.�from�
normal�diet�to�strict�vegetarian�diet)�or�if�you�are�suffering�from�states�of�renal�tubulary�acidosis�(RTA,�an�excess�of�
acid-forming� substances� in� the� blood� due� to� renal� dysfunction� (poor� kidney� function))� or� severe� infections� of� the�
urinary�tract�(structure�that�carries�urine),�as�your�doctor�may�need�to�adjust�the�dose�of�your�medicine.
Pregnancy�and�breast-feeding
Ask�your�doctor�or�pharmacist�for�advice�before�taking�any�medicine.
Tell�your�doctor�if�you�are�pregnant�or�planning�to�become�pregnant.�The�use�of�memantine�in�pregnant�women�is�not�
recommended.
Women�taking�Memantine�hydrochloride�should�not�breast-feed.
Driving�and�using�machines
Your�doctor�will�tell�you�whether�your�illness�allows�you�to�drive�and�to�use�machines�safely.
Also,�Memantine�hydrochloride�may�change�your�reactivity,�making�driving�or�operating�machinery�inappropriate.
3.�HOW�TO�TAKE�MEMANTINE�HYDROCHLORIDE
The�Memantine�hydrochloride�treatment�initiation�pack�is�only�to�be�used�for�the�beginning�of�the�treatment�with�
Memantine�hydrochloride.
Always�take�Memantine�hydrochloride�exactly�as�your�doctor�has�told�you.�You�should�check�with�your�doctor�or�
pharmacist�if�you�are�not�sure.
Dosage
The�recommended�treatment�dose�of�20�mg�per�day�is�achieved�by�a�gradual�increase�of�the�Memantine�hydrochloride�
dose�during�the�first�3�weeks�of�treatment.�The�treatment�scheme�is�also�indicated�on�the�treatment�initiation�pack.�Take�
one�tablet�once�a�day.
Week�1�(day�1-7):
Take�one�5�mg�tablet�once�a�day�(white,�oval,�biconvex)�for�7�days.
Week�2�(day�8-14):
Take�one�10�mg�tablet�once�a�day�(white,�biconvex,�two-side�scored)�for�7�days.
Week�3�(day�15-21):
Take�one�15�mg�tablet�once�a�day�(light�brown,�oval,�biconvex)�for�7�days.
Week�4�(day�22-28):
Take�one�20�mg�tablet�per�day�(pink,�oval,�biconvex)�for�7�days.
Week�1
Week�2
Week�3
Week�4�and�beyond



If�you�take�more�Memantine�hydrochloride�than�you�should
-�In�general,�taking�too�much�Memantine�hydrochloride�should�not�result�in�any�harm�to�you.�You�may�experience�
increased�symptoms�as�described�in�section�4.�“Possible�side�effects”.
-�If�you�take�a�large�overdose�of�Memantine�hydrochloride,�contact�your�doctor�or�get�medical�advice,�as�you�may�need�
medical�attention.
If�you�forget�to�take�Memantine�hydrochloride
-�If�you�find�you�have�forgotten�to�take�your�dose�of�Memantine�hydrochloride,�wait�and�take�your�next�dose�at�the�usual�
time.
-�Do�not�take�a�double�dose�to�make�up�for�a�forgotten�dose.
If�you�have�any�further�questions�on�the�use�of�this�product,�ask�your�doctor�or�pharmacist.
4.�POSSIBLE�SIDE�EFFECTS
Like�all�medicines,�this�medicine�can�cause�side�effects,�although�not�everybody�gets�them.
In�general,�the�observed�side�effects�are�mild�to�moderate.
Common�(may�affect�up�to�1�in�10�people):
•� Headache,�sleepiness,�constipation,�elevated�liver�function�tests,�dizziness,�balance�disorders,�shortness�of�breath,�
high�blood�pressure�and�drug�hypersensitivity
Uncommon�(may�affect�up�to�1�in�100�people):
•� Tiredness,� fungal� infections,� confusion,� hallucinations,� vomiting,� abnormal� gait,� heart� failure� and� venous� blood�
clotting�(thrombosis/thromboembolism)
Very�Rare�(may�affect�up�to�1�in�10,000�people):
•�Seizures
Not�known�(frequency�cannot�be�estimated�from�the�available�data):
•�Inflammation�of�the�pancreas,�inflammation�of�the�liver�(hepatitis)�and�psychotic�reactions
Alzheimer’s�disease�has�been�associated�with�depression,�suicidal�ideation�and�suicide.�These�events�have�been�reported�
in�patients�treated�with�memantine.
If�any�of�the�side�effects�gets�serious,�or�if�you�notice�any�side�effects�not�listed�in�this�leaflet,�please�tell�your�doctor�or�
pharmacist.
Reporting�of�side�effects
�If�you�get�any�side�effects,�talk�to�your�doctor,�pharmacist�or�nurse.�This�includes�any�possible�side�effects�not�listed�in�
this�leaflet.�You�can�also�report�side�effects�directly�via�the�Yellow�Card�Scheme�at:�www.mhra.gov.uk/yellowcard.
�By�reporting�side�effects�you�can�help�provide�more�information�on�the�safety�of�this�medicine.
5.�HOW�TO�STORE�MEMANTINE�HYDROCHLORIDE�TABLETS
Keep�this�medicine�out�of�the�sight�and�reach�of�children.
Do�not�use�this�medicine�after�the�expiry�date�which�is�stated�on�the�carton�and�the�blister�after�EXP.�The�expiry�date�
refers�to�the�last�day�of�that�month.
This�medicinal�product�does�not�require�any�special�storage�conditions.
Do�not�throw�away�any�medicines�via�wastewater�.�Ask�your�pharmacist�how�to�throw�away�medicines�you�no�longer�
use.�These�measures�will�help�to�protect�the�environment.
6.�CONTENTS�OF�THE�PACK�AND�OTHER�INFORMATION�
What�Memantine�hydrochloride�tablets�contains
The� active� substance� is� memantine� hydrochloride.� Each� film-coated� tablet� contains� 5/10/15/20� mg� memantine�
hydrochloride�equivalent�to�4.15/8.31/12.46/16.62�mg�memantine.
The� other� ingredients� for� Memantine� hydrochloride� 5/10/15� and� 20� mg� film-coated� tablets� are� microcrystalline�
cellulose,�croscarmellose�sodium,�colloidal�silicon�dioxide�and�magnesium�stearate,�all�in�the�tablet�core;�and�polyvinyl�
alcohol,�titanium�dioxide�(E171),�macrogol�3350,�talc�and�additional�for�Memantine�hydrochloride�15�mg�film-coated�
tablets�are�iron�oxide�yellow,�red�and�black�(E172)�and�for�Memantine�hydrochloride�20�mg�film-coated�tablets�are�iron�
oxide�yellow�and�red�(E172),�all�in�the�tablet�coating.
What�Memantine�hydrochloride�tablets�looks�like�and�contents�of�the�pack
Memantine�hydrochloride�5�mg�film-coated�tablets�are�presented�as�white,�oval,�biconvex�film-coated�tablets�
embossed�on�one�side�with�‘5’�and�with�the�dimensions�of�8.1mm�–�4.1mm.
Memantine� hydrochloride� 10� mg� film-coated� tablets� are� presented� as� white,� slim� through� the� middle,� biconvex�
film-coated�tablets�with�breaking�lines�on�both�sides�and�engraving�‘1�0’�on�one�side�and�with�the�dimensions�of�10mm�
–�5.6mm.
The�tablet�can�be�divided�in�equal�doses.
Memantine�hydrochloride�15�mg�film-coated�tablets�are�presented�as�light�brown,�oval,�biconvex�film-coated�tablets�
with�the�dimensions�of�12.3mm�–�6.6mm.
Memantine�hydrochloride�20�mg�film-coated�tablets�are�presented�as�pink,�oval,�biconvex�film-coated�tablets�with�the�
dimensions�of�13.5mm�–�7.3mm.
One�treatment�initiation�pack�contains�28�tablets�in�4�PVC/PE/PVDC/Al-blisters,�with�7�tablets�of�Memantine�5�mg�in,�
7�tablets�of�Memantine�10�mg,�7�tablets�of�Memantine�15�mg�and�7�tablets�of�Memantine�20�mg,�in�a�carton�box.
Marketing�Authorization�Holder
Abdi�Farma,�Unipessoal�Lda.
Quinta�da�Fonte,�Rua�dos�Malhões,
Edifício�D.�Pedro�I
2770�–�071�Paço�de�Arcos,�Portugal
abdifarma@abdiibrahim.com.tr
Manufacturer
GE Pharmaceuticals Ltd.
Industrial Zone, “Chekanitza-South” Area, 2410 Botevgrad Bulgaria
This�medicinal�product�is�authorised�in�the�Member�States�of�the�EEA�under�the�following�names:�
Belgium�(BE)


















Germany�(DE)








Hungary�(HU)












Netherlands
(NL) �






Poland�(PL)











Memantine�Abdi�5�mg�/�10�mg�/�15�mg�/�20�mg�comprimés�pelliculés,�filmtabletten,�
filmomhulde�tabletten�Starter�Pack
7�comprimés,�tabletten�of�Memantine�Abdi�5�mg�comprimés�pelliculés,�filmtabletten,�
filmomhulde�tabletten�
7�comprimés,�tabletten�of�Memantine�Abdi�10�mg�comprimés�pelliculés,�filmtabletten,�
filmomhulde�tabletten�
7�comprimés,�tabletten�of�Memantine�Abdi�15�mg�comprimés�pelliculés,�filmtabletten,�
filmomhulde�tabletten�
7�comprimés,�tabletten�of�Memantine�Abdi�20�mg�comprimés�pelliculés,�filmtabletten,�
filmomhulde�tabletten
Memantin�Abdi�Startpackung�5�mg�/�10�mg�/�15�mg�/�20�mg�Filmtabletten
7�tabletten�of�Memantin�Abdi�5�mg�filmtabletten
7�tabletten�of�Memantin�Abdi�10�mg�filmtabletten
7�tabletten�of�Memantin�Abdi�15�mg�filmtabletten
7�tabletten�of�Memantin�Abdi�20�mg�filmtabletten
Memantin�Abdi�5�mg�/�10�mg�/�15�mg�/�20�mg�filmtabletta�kezelés�kezd��csomag
7�tabletta�of�Memantin�Abdi�5�mg�filmtabletta
7�tabletta�of�Memantin�Abdi�10�mg�filmtabletta
7�tabletta�of�Memantin�Abdi�
15�mg�filmtabletta
7�tabletta�of�Memantin�Abdi�
20�mg�filmtabletta
Memantine�Abdi�5�mg�/�10�mg�/�15�mg�/�20�mg�filmomhulde�tabletten�startverpakking�
7�tabletten�of�Memantine�Abdi�5�mg�filmomhulde�tabletten
7�tabletten�of�Memantine�Abdi�10�mg�filmomhulde�tabletten
7�tabletten�of�Memantine�Abdi�15�mg�filmomhulde�tabletten�
7�tabletten�of�Memantine�Abdi�20�mg�filmomhulde�tabletten
Memantyny�Abdi�5�mg�/�10�mg�/�15�mg�/�20�mg�tabletki�powlekane�zestaw�
rozpoczynaj�cy�leczenie
7�tabletki�of�Memantyny�Abdi�5�mg�tabletki�powlekane
7�tabletki�of�Memantyny�Abdi�10�mg�tabletki�powlekane
7�tabletki�of�Memantyny�Abdi�15�mg�tabletki�powlekane
7�tabletki�of�Memantyny�Abdi�20�mg�tabletki�powlekane









This�leaflet�was�last�approved�in�02/2015.

5�mg�tablet�(red�blister)
10�mg�tablet�(black�blister)
15�mg�tablet�(green�blister)
20�mg�tablet�once�a�day�
(blue�blister)

Maintenance�dose
The�recommended�daily�dose�is�20�mg�once�a�day.
For�continuation�of�the�treatment�please�consult�your�doctor.
Dosage�in�patients�with�impaired�kidney�function
If�you�have�impaired�kidney�function,�your�doctor�will�decide�upon�a�dose�that�suits�your�condition.�In�this�case,�
monitoring�of�your�kidney�function�should�be�performed�by�your�doctor�at�specified�intervals.

Duration�of�treatment
Continue�to�take�Memantine�hydrochloride�as�long�as�it�is�of�benefit�to�you.�Your�doctor�should�assess�your�treatment�
on�a�regular�basis.

A20008307/01

Administration
Memantine�hydrochloride�should�be�administered�orally�once�a�day.�To�benefit�from�your�medicine�you�should�take�
it�regularly�every�day�at�the�same�time�of�the�day.�The�tablets�should�be�swallowed�with�some�water.
The�tablets�can�be�taken�with�or�without�food.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide